Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
VfBC13YRQLJXYBey
Listen
